NeuralTech
NeuralTech Raises $100M Growth to Transform Biotech
Quick Facts
NeuralTech Raises $100M Growth in Latest Funding Round
NeuralTech has successfully closed a $100M Growth funding round, marking a significant milestone in the company's growth trajectory. The round was led by GGV Capital, with participation from Thrive Capital.
Company Overview
Founded in 2023 and headquartered in Philadelphia, PA, NeuralTech has established itself in the Biotech space. Leading AI-powered analytics platform transforming data into actionable business insights
With a current valuation of $10B, the company has demonstrated strong market traction and investor confidence.
Investment Details
- Amount Raised: $100M Growth
- Valuation: $10B
- Lead Investor: GGV Capital
Future Outlook
As NeuralTech moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the biotech space.
Key Investors
About the Author
Related Company Reports
PrimeNet Raises $300M Series C to Transform Biotech
PrimeNet has secured $300M Series C in funding to accelerate growth and innovation. Leading machine learning platform automating enterprise workflows with advanced AI models...
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...